Summary:
- Price Zscore is at a recent 2 week high. A recent high ZScore means price movement is accelerating at a record speed.
- Volume Zscore is a recent 2 week high. A recent surge of ZScore means trading activities is accelerating at a record speed.
- Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
- RSI is at a high level of 72. A high level of RSI indicates the stock is overbought.
- MACD is crossing MACD signal line at 2.2. MACD crossing signal line is bullish signal.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today released a new report, "How to Address the Growing Behavioral Health Crisis Among Seniors," examining the growing and challenging problem of recognizing and engaging older Americans in need of behavioral healthcare.
A look at the shareholders of Ontrak, Inc. ( NASDAQ:OTRK ) can tell us which group is most powerful. Insiders often own...
Ontrak, Inc. (NASDAQ: OTRK, OTRKP) ("Ontrak" or the "Company"), a leading AI-powered and telehealth enabled, virtualized healthcare company, today announced that it has closed its previously announced underwritten public offering of 1,730,000 shares of its 9.50% Series A Cumulative Perpetual Preferred Stock (the "Series A Preferred Stock") at $24.75 per share, for gross proceeds to the Company of $42.8 million. The Company has granted the underwriters a 30-day option to purchase up to an additio...
Ontrak, Inc. (NASDAQ: OTRK, OTRKP) ("Ontrak" or the "Company"), a leading AI-powered and telehealth enabled, virtualized healthcare company, today announced that it has priced its previously announced underwritten public offering of 1,730,000 shares of its 9.50% Series A Cumulative Perpetual Preferred Stock (the "Series A Preferred Stock") at $24.75 per share, for gross proceeds to the Company of approximately $42.8 million. The Company has granted the underwriters a 30-day option to purchase up...
Ontrak, Inc. (NASDAQ: OTRK, OTRKP) ("Ontrak" or the "Company"), a leading AI-powered and telehealth enabled, virtualized healthcare company, today announced that it has commenced an underwritten public offering of shares of its Series A Cumulative Perpetual Preferred Stock (the "Series A Preferred Stock") with a liquidation preference of $25.00 per share. B. Riley Securities, Ladenburg Thalmann and William Blair are acting as book-running managers for the offering. Aegis Capital Corp., The Bench...
In this article you are going to find out whether hedge funds think Ontrak, Inc. (NASDAQ:OTRK) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]
Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced it ranked 279 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America, now in its 26th year. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019. In order to be eligible for Tec...
Pharma giants receive much attention due to their strong product pipelines and dividends. That said, there are many emerging healthcare and biotech plays that have the potential to offer compelling returns. This year, several stocks, including Moderna, Teladoc Health, Ontrak, Dexcom, and Acceleron Pharma, have significantly outpaced the broader market. But is there more room for growth?We will pick two rapidly growing companies, Teladoc and Ontrak, and use the TipRanks Stock Comparison tool to g...
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...